The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 90, Issue 6, Pages 504-510
Publisher
Wiley
Online
2015-03-03
DOI
10.1002/ajh.23988
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multi-color flow cytometric immunophenotyping for detection of minimal residual disease in AML: past, present and future
- (2014) J M Jaso et al. BONE MARROW TRANSPLANTATION
- Persistence ofDNMT3Amutations at long-term remission in adult patients with AML
- (2014) Gro G. Pløen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
- (2014) R B Walter et al. LEUKEMIA
- Acute myeloid leukemia: 2013 update on risk-stratification and management
- (2013) Elihu H. Estey AMERICAN JOURNAL OF HEMATOLOGY
- Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
- (2013) R. B. Walter et al. BLOOD
- Should evaluation for minimal residual disease be routine in acute myeloid leukemia?
- (2013) Elaine Coustan-Smith et al. CURRENT OPINION IN HEMATOLOGY
- Residual disease in AML, a target that can move in more than one direction
- (2013) Michael R. Loken CYTOMETRY PART B-CLINICAL CYTOMETRY
- Tumor heterogeneity makes AML a “moving target” for detection of residual disease
- (2013) W. Zeijlemaker et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia
- (2013) Sylvie D. Freeman et al. JOURNAL OF CLINICAL ONCOLOGY
- High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study
- (2013) Monique Terwijn et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Validation of a Next-Generation Sequencing Screen for Mutational Hotspots in 46 Cancer-Related Genes
- (2013) Rajesh R. Singh et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Minimal residual disease in acute myeloid leukaemia
- (2013) Christopher S. Hourigan et al. Nature Reviews Clinical Oncology
- Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group
- (2012) M. R. Loken et al. BLOOD
- When it comes to MRD, AML != ALL
- (2012) E. Paietta BLOOD
- The Origin and Evolution of Mutations in Acute Myeloid Leukemia
- (2012) John S. Welch et al. CELL
- Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia
- (2012) Hiroto Inaba et al. JOURNAL OF CLINICAL ONCOLOGY
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Clonal Architecture of Secondary Acute Myeloid Leukemia
- (2012) Matthew J. Walter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
- (2011) F. Buccisano et al. BLOOD
- Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia: Methods and Best Applications
- (2011) Jeffrey L. Jorgensen et al. Clinical Lymphoma Myeloma & Leukemia
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now